Andrea R. Hagemann

Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer

Robert L. Coleman, Gini F. Fleming, Mark F. Brady et al. · New England Journal of Medicine · 2019 · 886 citations · Full text

Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study

Dmitriy Zamarin, Robert A. Burger, Michael W. Sill et al. · Journal of Clinical Oncology · 2020 · 329 citations · Full text

NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024

Mary B. Daly, Tuya Pal, Kara N. Maxwell et al. · Journal of the National Comprehensive Cancer Network · 2023 · 249 citations · Full text

A Dendritic Cell Vaccine Pulsed with Autologous Hypochlorous Acid-Oxidized Ovarian Cancer Lysate Primes Effective Broad Antitumor Immunity: From Bench to Bedside

Cheryl Lai-Lai Chiang, Lana E. Kandalaft, János L. Tanyi et al. · Clinical Cancer Research · 2013 · 215 citations · Full text

Social approach–avoidance behavior of inbred mouse strains towards DBA/2 mice

Edward S. Brodkin, Andrea R. Hagemann, Sondra Maureen Nemetski et al. · Brain Research · 2004 · 169 citations

Animal Behaviour, Behavioral Sciences, Behavioral Neuroscience +8